PuSH - Publikationsserver des Helmholtz Zentrums München

Zeitschriften-Browsing

48 Datensätze gefunden.
Zum Exportieren der Ergebnisse bitte einloggen.
▮◀ ◀◀ 1 ... 2 ... 3 ... ▶▶ ▶▮
Alle Publikationen dieser Seite in den Korb legen
21.
Ebinger, S. ; Mura, L. ; Grunert, M. & Jeremias, I.: Drug sensitivity of patient-derived ALL tumor cells is impaired by co-culture with feeder cells mimicking the in vivo micro-environment. Ann. Hematol. 94, S88-S89 (2015)
22.
Fasan, A.* et al.: Evaluation of IDH1G105 polymorphism as prognostic marker in intermediate-risk AML. Ann. Hematol. 94, 1991-2001 (2015)
23.
Finkenzeller, C. ; Carlet, M. & Jeremias, I.: Single cell clones from a patient with all show different drug sensitivity and growth behavior in vivo. Ann. Hematol. 94, S89 (2015)
24.
Greif, P.A. et al.: Genetic evolution in relapsed AML. Ann. Hematol. 94, S51-S52 (2015)
25.
Köhnke, T. et al.: Flow cytometric analysis of minimal residual disease in acute myeloid leukemia. Ann. Hematol. 94, S30-S31 (2015)
26.
Lichtenegger, F.S. et al.: Next-generation dendritic cells for immunotherapy of acute myeloid leukemia. Ann. Hematol. 94, S53 (2015)
27.
Reiter, K. et al.: Visualization of AML-specific FLT3 mutants and differential downstream signaling. Ann. Hematol. 94, S82 (2015)
28.
Tischer, J.* et al.: Virus infection in HLA-haploidentical hematopoietic stem cell transplantation: Incidence in the context of immune recovery in two different transplantation settings. Ann. Hematol. 94, 1677-1688 (2015)
29.
Vick, B. et al.: In vivo imaging facilitates reliable and sensitive monitoring of preclinical in vivo treatment trials in the individualized xenograft mouse model of AML. Ann. Hematol. 94, S83-S84 (2015)
30.
Vosberg, S. et al.: Detection of chromosome 9q deletion in Acute Myeloid Leukemia (AML) patients using targeted sequencing data. Ann. Hematol. 94, S84 (2015)
31.
Zoellner, A.K.* et al.: Temsirolimus acts as additive with bendamustine in aggressive lymphoma. Ann. Hematol. 95, 403-407 (2015)
32.
Dufour, A.* et al.: Monoallelic CEBPA mutations in normal karyotype acute myeloid leukemia: Independent favorable prognostic factor within NPM1 mutated patients. Ann. Hematol. 91, 1051-1063 (2012)
33.
Eisele, L.* et al.: Prevalence and progression of monoclonal gammopathy of undetermined significance and light-chain MGUS in Germany. Ann. Hematol. 91, 243-248 (2012)
34.
Hutter, G. et al.: The proteasome inhibitor bortezomib targets cell cycle and apoptosis and acts synergistically in a sequence-dependent way with chemotherapeutic agents in mantle cell lymphoma. Ann. Hematol. 91, 847-856 (2012)
35.
Schneider, F.* et al.: Age-dependent frequencies of NPM1 mutations and FLT3-ITD in patients with normal karyotype AML (NK-AML). Ann. Hematol. 91, 9-18 (2012)
36.
Hutter, G. et al.: Allelic genotyping reveals a hierarchy of genomic alterations in mantle cell lymphoma associated to cell proliferation. Ann. Hematol. 88, 821-828 (2009)
37.
Göttlicher, M.: Valproic acid: An old drug newly discovered as inhibitor of histone deacetylases. Ann. Hematol. 83, 1, 91-92 (2004)
38.
Lenz, G.* ; Hutter, G. ; Hiddemann, W. & Dreyling, M.: Promoter methylation and expression of DNA repair genes hMLH1 and MGMT in acute myeloid leukemia. Ann. Hematol. 83, 628-633 (2004)
39.
Stanglmaier, M. ; Reis, S. & Hallek, M.: Rituximab and Alemtuzumab induce a nonclassic, caspase-independent apoptotic pathway in B-lymphoid cell lines and in chronic lymphocytic leukemia cells. Ann. Hematol. 83, 634-645 (2004)
40.
Pihusch, R.* et al.: Platelet flow cytometric findings in patients undergoing conditioning therapy for allogeneic hematopoitic stem cell transplantation. Ann. Hematol. 81, 454-461 (2002)
▮◀ ◀◀ 1 ... 2 ... 3 ... ▶▶ ▶▮